Valeritas Announces V-Go & #194; & #174; Received Preferred Status on OptumRx Formularies

Bridgewater, N.J., Jan. 14, 2019 (Globe Newswire) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced that V-Go is Preferred on the OptumRx formulary.“We are very excited that V-Go is now Preferred on OptumRx formularies,” said Valeritas CEO, John Timberlake.“V-Go helps patients simplify...This story is related to the following:Pharmaceuticals
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news